More than a quarter of patients with renal cell carcinoma on active surveillance experience spontaneous tumor regression, researchers report.
Subscribe Login Register Log out My Profile Subscriber Services Search EBLADE ENTER-TO-WIN BLADE REWARDS BLADE VAULT / REPRINTS OBITUARIES JOBS CLASSIFIEDS BLADE HOMES HOMES WEEKLY ADS EVENTS CONTACT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback